Literature DB >> 2885383

Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes.

D L Stevens, J Mitten, C Henry.   

Abstract

Two toxins, alpha (phospholipase C) and theta (oxygen-labile hemolysin), were purified from Clostridium perfringens type A and assayed for toxic effects on human polymorphonuclear leukocytes (PMNLs). Crude preparations containing both toxins totally inhibited chemotaxis and chemiluminescence responses of PMNLs and reduced PMNL viability. Purified alpha toxin did not alter PMNL viability, chemotactic responsiveness, or morphology but did enhance opsonized zymosan-induced PMNL chemiluminescence over a wide range of toxin concentrations. theta Toxin, at 12.5 hemolytic units (HU) per 10(5) PMNLs, reduced cell viability and induced marked PMNL morphological changes. Concentrations of theta toxin between 4 and 32 HU per 10(5) PMNLs inhibited PMNL chemiluminescence in a dose-dependent manner, whereas a lower concentration enhanced the PMNL chemiluminescent response to opsonized zymosan. Effects on chemotaxis were also dose dependent. Increased PMNL random migration was observed at a concentration of theta toxin of 0.06 HU per 2.5 X 10(5) PMNLs (P less than .05), whereas concentrations of greater than 0.08 HU per 2.5 X 10(5) PMNLs reduced both directed and random migration (P less than .05).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885383     DOI: 10.1093/infdis/156.2.324

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens.

Authors:  Jackie K Cheung; Anthony L Keyburn; Glen P Carter; Anouk L Lanckriet; Filip Van Immerseel; Robert J Moore; Julian I Rood
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Degranulation of human neutrophils after exposure to bacterial phospholipase C.

Authors:  T K Wazny; N Mummaw; B Styrt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

Review 3.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

4.  Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils.

Authors:  Masataka Oda; Syusuke Ikari; Takayuki Matsuno; Yuka Morimune; Masahiro Nagahama; Jun Sakurai
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.

Authors:  Meredith L Hughes; Rachael Poon; Vicki Adams; Sameera Sayeed; Juliann Saputo; Francisco A Uzal; Bruce A McClane; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

6.  Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.

Authors:  R K Tweten
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 7.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

8.  Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.

Authors:  David K O'Brien; Stephen B Melville
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Arcanobacterium haemolyticum phospholipase D is genetically and functionally similar to Corynebacterium pseudotuberculosis phospholipase D.

Authors:  W A Cuevas; J G Songer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  M M Huycke; C A Spiegel; M S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.